2. The project will be priced at 240million yuan according to the agreement, and the achievement transformation will be implemented by means of transfer.
Academician you Zheng, President of Huazhong University of science and technology, Professor zhangyonghui, Dean of College of pharmacy, shareholders of jinnuosai zhangxiangyang, Liu Ao, Hu Fengrui, Li Xin and general manager he long attended the signing ceremony. The ceremony was presided over by Professor liaoxiaofei, President of the Academy of science and technology development.
Anoectochilus roxburghii is a rare and precious herbal medicine, known as "king of medicine", "golden herb", "divine medicine", "bird ginseng" and other laudatory names. It has pharmacological activities such as liver protection, lowering blood lipids, lowering blood glucose, improving immunity, and antioxidation. With the support of the National Natural Science Foundation of China, major new drug development projects and the "863" program, the R & D team of anoectochilin class I new drugs at Huazhong University of science and technology has carried out systematic and in-depth research since 2000, and for the first time clarified that the main active ingredient of anoectochilin is anoectochilin, which has a good liver protective effect, and has a good protective effect on non-alcoholic steatohepatitis (NASH), autoimmune hepatitis, alcoholic liver injury, cholestatic liver injury, radiation-induced liver injury, and liver fibrosis, and has moderate hypoglycemic and hypolipidemic effects, and is basically non-toxic. The project team has completed the basic source determination, tissue culture and quality standard formulation of Anoectochilus roxburghii, formed a mature anoectochilin extraction and purification process, and completed the preclinical research of class I new drugs such as pharmacology, toxicology, drug metabolism, drug stability and pharmaceutics. It will apply for the national class I new drugs in March.
Professor zhangyonghui, head of anoectoside class I new drug research and development team, said that the research results have independent intellectual property rights and significant competitive advantages. This achievement transformation will strongly promote the follow-up clinical research of this new drug research and development. The developed drugs will fill many gaps in liver protection drugs at home and abroad and contribute to the development of domestic innovative drugs with independent intellectual property rights.
He long, general manager of jinnuosai, said that jinnuosai is committed to opening up the "last mile" of scientific and technological innovation, helping to transform scientific and technological achievements in Colleges and universities, and unblocking the channel of combining scientific and technological achievements with market economy. The company is willing to adhere to the principles of resource sharing, innovation synchronization and complementary advantages, actively promote the deepening of cooperation with Huazhong University, and work together to achieve the transformation of scientific research projects.
240million! Achievement transformation of anoectoside new drug project of Huazhong University of science and technology
Release Date：2023/3/6 15:30:37